- Home
- AKA vs ANIK Comparison
AKA vs ANIK Comparison
Compare AKA & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKA | ANIK |
|---|---|---|
| Founded | 2018 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.8M | 134.8M |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | AKA | ANIK |
|---|---|---|
| Price | $12.00 | $9.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $24.33 | $16.00 |
| AVG Volume (30 Days) | 4.3K | ★ 127.3K |
| Earning Date | 03-05-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $595,281,000.00 | $112,806,000.00 |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $4.70 | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.44 | ★ 30.55 |
| 52 Week Low | $7.00 | $7.87 |
| 52 Week High | $18.41 | $18.37 |
Technical Indicators
Market Signals| Indicator | AKA | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 52.83 | 44.58 |
| Support Level | $11.50 | $9.16 |
| Resistance Level | $12.29 | $9.60 |
| Average True Range (ATR) | 0.69 | 0.23 |
| MACD | 0.09 | -0.01 |
| Stochastic Oscillator | 75.84 | 28.78 |
Price Performance
Historical ComparisonAbout AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.